Molavi Chapter 20 - Bone Marrow Flashcards

1
Q

Identify those cells

A
  1. Erythroid precursors - distinct rim of clear cytoplasm. Centrally located, round nuclei that gradually become smaller and denser as they mature. “Looks kind of like a lymphocyte” until it accumulates heme.
  2. Myeloid precursors - Everything else. Also accumulate granules.
  3. Megakaryocytes - Easy to identify.
  4. Maturing neutrophils - Bands, easy to identify.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Lymphoid cells in the marrow

A

Generally should not be seen – especially immature lymphoid cells.

Hematogones (non-neoplastic B cell precursors) are the exception and can be more frequent in children.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Identify the cell marked by the arrowhead

A

This is a blast. Note that we are on Giemsa-Wright cytology, not H and E histology.

The blast nucleus is large and round with very finely textured chromatin and a nonstaining nucleolus that shows up as a “hole” in the chromatin.

The more differentiated precursors (promyelocytes, melocytes) have similar nuclei but acquire cytoplasmic features (granules, a hof).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

A normal promyelocyte should have a cearly visible. . .

A

. . . Golgi apparatus

The absence of this clear Golgi apparatus and increased toxic granulation suggests a dysplastic promyelocyte, such as in APML.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Nucleoli vs Vacuoles

A

In normal, healthy blasts, nucleoli can look lighter, almost like punched-out holes.

However, true vacuoles within the nucleus are a sign of dysplasia.

Differentiating the two is important.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Erythroblasts

A

Often described as having “royal blue” cytoplasm and very round nuclei.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Estimating the cellularity of marrow

A

Roughly 100% - Age (for those ages ~20-70)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
A

Marrow fibrosis

The marrow appears hypercellular at low power, but on high power has clear bands of fibrosis giving it a “streaming” texture.

Hematopoietic cells are divided into nests and chains.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
A

Chronic myeloid leukemia

The marrow is hypercellular and full of small, hypolobated megakaryoytes and mature neutrophils

Remember: Numerous neutrophils may indicate CML, but sheets of multiple lineages of myeloid cells may indicate infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Any more than __% of blasts in the bone marrow is abnormal.

More than __% of blasts is necessary for a diagnosis of most leukemias.

A

Any more than 5% of blasts in the bone marrow is abnormal.

More than 20% of blasts is necessary for a diagnosis of most leukemias.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Dyserythropoiesis features

A
  • Binucleated red cells
  • Red cell precursors with irregular nuclear membranes
  • “Megaloblastoid change”
    • A softer sign
    • “Sliced salami” nuclei within mature (pale gray) cytoplasm
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Dysgranulopoiesis features

A
  • Abnormalities in nuclear lobation (“Pelgeroid”, aka bilobated like spectacles)
  • Abnormal granluation (absence of granules or occasionally coarse basophilic granules)
  • Hypersegmented neutrophils suggest megaloblastic anemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Plasma cell dyscrasia spectrum

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Plasma cells making up >__% of bone marrow cells indicates a possible plasma cell dyscrasia.

A

Plasma cells making up >10% of bone marrow cells indicates a possible plasma cell dyscrasia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Prussian blue staining of bone marrow

A

This staining shows sideroblasts. Some sideroblasts are present at baseline, but the proportion may change with pathology:

  • Decreased in iron deficiency anemia
  • Increased in sideroblastic anemia (especially ringed sideroblasts, shown here)
    • Heritable: One of many AD or X-linked mutations in heme metabolism
    • Acquired: Lead toxicity, somatic SF3B1 mutation (MDS, splicing error), B6 deficiency, Cu deficiency, Zn toxicity, some medications.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

5 steps to categorizing bone marrow disorders

A
  1. What’s the cellularity? (normal/hyper/hypo)
  2. Is there a dominant cell line?
  3. Are there too many blasts?
  4. Are there too many plasma cells?
  5. Are there any lymphocytes?
17
Q

Ddx for hypercellular marrow

A
  • Physiologic response to anemia (hemolysis, infection, no dysplasia)
  • Ineffective hematopoiesis (megaloblastic, HIV)
  • Myelodysplasia (dysplasia in some cell line, <20% blasts)
  • Myeloproliferative disorder
  • Acute leukemia (>20% blasts with or without dysplasia)
  • Other neoplasm (lymphoma, myeloma, metastatic cancer)
    • Might present as myelophthisis
18
Q

Ddx for hypocellular marrow

A
  • Aplastic anemia
  • Chemotherapy or toxin-induced
  • Infection
  • Hypocellular forms of myelodysplatic syndrome or AML (blasts are still increased!)
19
Q

Diagnostic features of myelodysplastic syndrome

A
  • Dysplasia of at least one cell line
  • <20% blasts within the bone marrow
20
Q

Blasts, MDS, and leukemia

A

Blast % is important in diagnosis of both diseases.

Generally, leukemias have >20% blasts as a requirement for diagnosis, and MDS must have <20% blasts to be MDS.

However, an MDS may progress to an AML, in which case blasts will go from <20% to >20%. Be aware that this transition is possible.

21
Q

Nondiagnostic supportive findings of MDS

A
  • Tend to have an erythyroid predominance in the marrow, since the body is appropriately trying to adapt to its anemia
    • Decreased M/E ratio
  • Ringed sideroblasts, excess blasts, or defining mutations may be involved
22
Q

“MDS with ringed sideroblasts”

A

>15% ringed sideroblasts or iron stain

23
Q

Subcategorizing a diagnosis of MDS

A
  • “MDS with single lineage dysplasia”
    • Erythroid dysplasia with anemia and <5% blasts.
    • May or may not have “with ringed sideroblasts”
  • “MDS with multilineage dysplasia”
    • Two or more (usually three) lineages
    • Dysplasia must be seen in >10% of given cell line to be significant
    • <5% blasts
    • May or may not have “with ringed sideroblasts”
  • “MDS with excess blasts”
    • MDS-EB1 is 5-9% blasts
    • MDS-EB2 is 10-19% blasts OR presence of Auer rods OR >5% circulating blasts (high risk of transformation to AML)
24
Q

MDS/MPN

A

The overlap category between MDS and MPN

Chronic myelomonocytic leukemia (CMML) is the classic example

It has dysplasia, anemia, thrombocytopenia, monocytosis, <20% blasts and NO Philidelphia chromosome.

25
Q

2016 WHO classification of acute leukemias

A
26
Q
A

Myeloma

Just sheets and sheets of plasma cells with eccentric nuclei, perinuclera hofs, and clockface chromatin.

27
Q
A

Paratrabecular lymphocytic collection within bone marrow

This pattern favors a follicular lymphoma

28
Q
A

Nonparatrabecular lymphoid aggregate within the bone marrow

Benign lymphoid aggregates are common in elderly patients, however in a younger patient this raises concern for CLL/SLL.

29
Q
A

Interstitial lymphocytic infiltration within the bone marrow

Lymphocytes are intermixed among normal marrow elements without any discrete lymphoid aggregates. May be hard to pick out on simple H&E stain.

Suggests CLL/SLL or Mantle cell lymphoma, especially if in conjunction with nonparatrabecular lymphoid aggregates.

30
Q
A

Diffuse lymphocytic infiltration of bone marrow

Sheets of lymphocytes replacing normal marrow elements

Typical of a more aggressive lymphoma, such as Burkitt’s or DLBCL, or an advanced CLL/SLL.

31
Q

Features of a benign lymphoid aggregate in the bone marrow

A
  • Heterogeneous mixture of lymphocytes, histiocytes, and plasma cells
    • Stains with CD3, CD20, CD138
  • Well-markated borders
  • Germinal centers
  • Patient of older age